Literature DB >> 30721369

Objective assessment of WHO/ECOG performance status.

Miha Sok1,2, Miha Zavrl3, Boris Greif3, Matevž Srpčič3.   

Abstract

PURPOSE: Performance status is an important factor in determining quality of life, the choice of treatment, and prognostic tool in patients. All scoring systems currently in use measure the patient's performance subjectively. A new method of objective assessment of performance ECOG/WHO grades 2 and 3 was constructed and tested.
METHODS: A performance meter-an adapted USB data logger with a mercury tilt switch-was constructed. The device was tested in a feasibility study on 33 residents of a retirement home. Parallel to the objective assessment, each resident gave their own estimate of their performance, and each resident was in turn assessed by the nursing staff.
RESULTS: With the performance meter, 4 residents (12%) were assessed as PS ≥ 3 in comparison with 8 (24%) and 7 (21%) residents with an ECOG score ≥ 3 estimated by patients themselves and nursing staff respectively.
CONCLUSION: Subjective scoring-estimated by patients themselves and by nursing staff-showed underestimation of patients' performance. In 12% of patients, a better performance score was observed with objective measurement in comparison with subjective assessment. Performance meter could be a useful tool for health care professionals for type of care decisions.

Entities:  

Keywords:  ECOG score; Objective score; Performance meter; Performance status

Mesh:

Year:  2019        PMID: 30721369     DOI: 10.1007/s00520-018-4597-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  18 in total

Review 1.  Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.

Authors:  Marco Maltoni; Augusto Caraceni; Cinzia Brunelli; Bert Broeckaert; Nicholas Christakis; Steffen Eychmueller; Paul Glare; Maria Nabal; Antonio Viganò; Philip Larkin; Franco De Conno; Geoffrey Hanks; Stein Kaasa
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

2.  Patient-focused endpoints in advanced cancer: criterion-based validation of accelerometer-based activity monitoring.

Authors:  Richard J E Skipworth; Guro B Stene; Max Dahele; Paul O Hendry; Alexandra C Small; David Blum; Stein Kaasa; Peter Trottenberg; Lukas Radbruch; Florian Strasser; Tom Preston; Kenneth C H Fearon; Jorunn L Helbostad
Journal:  Clin Nutr       Date:  2011-07-05       Impact factor: 7.324

3.  Observer error in grading performance status in cancer patients.

Authors:  A E Taylor; I N Olver; T Sivanthan; M Chi; C Purnell
Journal:  Support Care Cancer       Date:  1999-09       Impact factor: 3.603

4.  Should patient-rated performance status affect treatment decisions in advanced lung cancer?

Authors:  Esther Dajczman; Goulnar Kasymjanova; Harvey Kreisman; Nelda Swinton; Carmela Pepe; David Small
Journal:  J Thorac Oncol       Date:  2008-10       Impact factor: 15.609

5.  Construction of a new, objective prognostic score for terminally ill cancer patients: a multicenter study.

Authors:  Sang-Yeon Suh; Youn Seon Choi; Jae Yong Shim; Young Sung Kim; Chang Hwan Yeom; Daeyoung Kim; Shin Ae Park; Sooa Kim; Ji Yeon Seo; Su Hyun Kim; Daegyeun Kim; Sung-Eun Choi; Hong-Yup Ahn
Journal:  Support Care Cancer       Date:  2009-04-21       Impact factor: 3.603

6.  Predictive model for survival in patients with advanced cancer.

Authors:  Edward Chow; Mohamed Abdolell; Tony Panzarella; Kristin Harris; Andrea Bezjak; Padraig Warde; Ian Tannock
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

7.  Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer.

Authors:  Daniel J Sargent; Claus Henning Köhne; Hanna Kelly Sanoff; Brian M Bot; Matthew T Seymour; Aimery de Gramont; Ranier Porschen; Leonard B Saltz; Philippe Rougier; Christopher Tournigand; Jean-Yves Douillard; Richard J Stephens; Axel Grothey; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

8.  Validation of prognostic scores for survival in cancer patients beyond first-line therapy.

Authors:  Olivier Trédan; Isabelle Ray-Coquard; Gisèle Chvetzoff; Paul Rebattu; Agathe Bajard; Sylvie Chabaud; David Pérol; Chadi Saba; Florent Quiblier; Jean-Yves Blay; Thomas Bachelot
Journal:  BMC Cancer       Date:  2011-03-15       Impact factor: 4.430

9.  The Australia-modified Karnofsky Performance Status (AKPS) scale: a revised scale for contemporary palliative care clinical practice [ISRCTN81117481].

Authors:  Amy P Abernethy; Tania Shelby-James; Belinda S Fazekas; David Woods; David C Currow
Journal:  BMC Palliat Care       Date:  2005-11-12       Impact factor: 3.234

10.  Performance status score: do patients and their oncologists agree?

Authors:  S P Blagden; S C Charman; L D Sharples; L R A Magee; D Gilligan
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640

View more
  10 in total

1.  Impact of the COVID-19 pandemic on urological cancers: The surgical experience of two cancer hubs in London and Milan.

Authors:  Maria J Monroy-Iglesias; Sonpreet Rai; Francesco A Mistretta; Graham Roberts; Harvey Dickinson; Beth Russell; Charlotte Moss; Rita De Berardinis; Matteo Ferro; Gennaro Musi; Christian Brown; Rajesh Nair; Ramesh Thurairaja; Archana Fernando; Paul Cathcart; Azhar Khan; Prokar Dasgupta; Sachin Malde; Marios Hadijpavlou; Saoirse Dolly; Kate Haire; Marta Tagliabue; Ottavio de Cobelli; Ben Challacombe; Mieke Van Hemelrijck
Journal:  BJUI Compass       Date:  2022-01-27

2.  Response monitoring in metastatic breast cancer: a comparison of survival times between FDG-PET/CT and CE-CT.

Authors:  Mohammad Naghavi-Behzad; Marianne Vogsen; Rasmus Mølgård Vester; Maiken Madsen Bjerregaard Olsen; Hjalte Oltmann; Poul-Erik Braad; Jon Thor Asmussen; Oke Gerke; Werner Vach; Kristian Kidholm; Annette Raskov Kodahl; Wolfgang Weber; Malene Grubbe Hildebrandt
Journal:  Br J Cancer       Date:  2022-01-10       Impact factor: 9.075

3.  Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis.

Authors:  Zhongyin Yang; Chen Li; Wentao Liu; Yanan Zheng; Zhenglun Zhu; Zichen Hua; Zhentian Ni; Sheng Lu; Min Yan; Chao Yan; Zhenggang Zhu
Journal:  Chin J Cancer Res       Date:  2020-08       Impact factor: 5.087

4.  Barriers to Clinical Trial Participation: Comparative Study Between Rural and Urban Participants.

Authors:  Dinesh Pal Mudaranthakam; Byron Gajewski; Hope Krebill; James Coulter; Michelle Springer; Elizabeth Calhoun; Dorothy Hughes; Matthew Mayo; Gary Doolittle
Journal:  JMIR Cancer       Date:  2022-04-21

5.  Selective inhibition of PI3K110α as a novel therapeutic strategy for cetuximab‑resistant oral squamous cell carcinoma.

Authors:  Hiroki Tsuchihashi; Tomofumi Naruse; Souichi Yanamoto; Kohei Okuyama; Kohei Furukawa; Keisuke Omori; Masahiro Umeda
Journal:  Oncol Rep       Date:  2020-07-07       Impact factor: 3.906

6.  A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.

Authors:  Costantine Albany; Zeeshan Fazal; Ratnakar Singh; Emmanuel Bikorimana; Nabil Adra; Nasser H Hanna; Lawrence H Einhorn; Susan M Perkins; George E Sandusky; Brock C Christensen; Harold Keer; Fang Fang; Kenneth P Nephew; Michael J Spinella
Journal:  Cancer Med       Date:  2020-11-01       Impact factor: 4.452

7.  Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced Cancer Patients.

Authors:  Rongrong Fan; Xuying Li; Siyu Yang; Xiaofan Bu; Yongyi Chen; Ying Wang; Cuiling Qiu
Journal:  Pain Res Manag       Date:  2022-04-14       Impact factor: 2.667

8.  Hormonal Changes after R-CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study.

Authors:  Worapaka Manosroi; Jiraporn Chirayucharoensak; Chatree Chai-Adisaksopha; Phichayut Phinyo
Journal:  Medicina (Kaunas)       Date:  2022-05-26       Impact factor: 2.948

9.  Clinical impact of pretreatment albumin-globulin ratio in patients with colorectal cancer: A meta-analysis.

Authors:  Jian-Ying Ma; Gang Liu; Liang-Zhi Pan; Min Hu; Zhong-Zhong Zhu
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

10.  Continuity of Cancer Care: The Surgical Experience of Two Large Cancer Hubs in London and Milan.

Authors:  Maria J Monroy-Iglesias; Marta Tagliabue; Harvey Dickinson; Graham Roberts; Rita De Berardinis; Beth Russell; Charlotte Moss; Sophie Irwin; Jonathon Olsburgh; Ivana Maria Francesca Cocco; Alexis Schizas; Sarah McCrindle; Rahul Nath; Aina Brunet; Ricard Simo; Chrysostomos Tornari; Parthi Srinivasan; Andreas Prachalias; Andrew Davies; Jenny Geh; Stephanie Fraser; Tom Routledge; RuJun Ma; Ella Doerge; Ben Challacombe; Raj Nair; Marios Hadjipavlou; Rosaria Scarpinata; Paolo Sorelli; Saoirse Dolly; Francesco Alessandro Mistretta; Gennaro Musi; Monica Casiraghi; Alessia Aloisi; Andrea Dell'Acqua; Donatella Scaglione; Stefania Zanoni; Daniele Rampazio Da Silva; Daniela Brambilla; Raffaella Bertolotti; Giulia Peruzzotti; Angelo Maggioni; Ottavio de Cobelli; Lorenzo Spaggiari; Mohssen Ansarin; Fabrizio Mastrilli; Sara Gandini; Urvashi Jain; Hisham Hamed; Kate Haire; Mieke Van Hemelrijck
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.